Stock 600628 SHANGHAI NEW WORLD CO., LTD
Add to a list
To use this feature you must be a member
Log inSign up

Financials Shanghai New World Co., Ltd

Equities

600628

CNE0000006X1

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 23:00:00 25/04/2024 BST 		5-day change 1st Jan Change
6.03 CNY +1.52% Intraday chart for Shanghai New World Co., Ltd +3.25% -13.98%
04-12 Shanghai New World Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Shanghai New World Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 4,101 6,094 5,046 5,013 4,942 4,535
Enterprise Value (EV) 1 2,207 4,699 3,899 3,727 3,697 3,141
P/E ratio 15.1 x 157 x 70.9 x 70.5 x -95.5 x 140 x
Yield 2.05% 0.32% 0.71% 0.71% 0.39% 0.43%
Capitalization / Revenue 1.48 x 3.69 x 4.82 x 4.3 x 5.81 x 4 x
EV / Revenue 0.79 x 2.84 x 3.73 x 3.2 x 4.35 x 2.77 x
EV / EBITDA 5.13 x 48.2 x 21.5 x 16.6 x 54.8 x 13 x
EV / FCF 20 x 8.17 x -8.44 x 32.4 x 62.4 x 43.5 x
FCF Yield 4.99% 12.2% -11.8% 3.09% 1.6% 2.3%
Price to Book 0.92 x 1.41 x 1.16 x 1.15 x 1.17 x 1.09 x
Nbr of stocks (in thousands) 646,875 646,875 646,875 646,875 646,875 646,875
Reference price 2 6.340 9.420 7.800 7.750 7.640 7.010
Announcement Date 11/04/19 16/04/20 14/04/21 29/04/22 12/04/23 12/04/24
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 2,776 1,653 1,046 1,166 850 1,134
EBITDA 1 430.2 97.51 181.5 224.1 67.53 240.9
EBIT 1 341.4 -5.288 40.21 79.57 -79.06 92.71
Operating Margin 12.3% -0.32% 3.84% 6.83% -9.3% 8.18%
Earnings before Tax (EBT) 1 365.3 49.44 90.41 113.5 -59.57 65.04
Net income 1 272.9 36.62 70.63 69.46 -52.02 31.66
Net margin 9.83% 2.22% 6.75% 5.96% -6.12% 2.79%
EPS 2 0.4200 0.0600 0.1100 0.1100 -0.0800 0.0500
Free Cash Flow 1 110.1 575.3 -461.8 115.1 59.27 72.21
FCF margin 3.97% 34.8% -44.14% 9.87% 6.97% 6.37%
FCF Conversion (EBITDA) 25.6% 590% - 51.35% 87.76% 29.98%
FCF Conversion (Net income) 40.36% 1,570.79% - 165.66% - 228.1%
Dividend per Share 2 0.1300 0.0300 0.0550 0.0550 0.0300 0.0300
Announcement Date 11/04/19 16/04/20 14/04/21 29/04/22 12/04/23 12/04/24
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 1,894 1,395 1,147 1,286 1,245 1,394
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 110 575 -462 115 59.3 72.2
ROE (net income / shareholders' equity) 6.22% 0.85% 1.64% 1.61% -1.2% 0.75%
ROA (Net income/ Total Assets) 3.66% -0.05% 0.4% 0.82% -0.84% 1.02%
Assets 1 7,449 -68,586 17,796 8,522 6,226 3,115
Book Value Per Share 2 6.860 6.670 6.710 6.730 6.510 6.460
Cash Flow per Share 2 2.110 2.430 2.560 1.800 2.000 1.770
Capex 1 17 752 148 78.3 35 145
Capex / Sales 0.61% 45.48% 14.13% 6.72% 4.12% 12.82%
Announcement Date 11/04/19 16/04/20 14/04/21 29/04/22 12/04/23 12/04/24
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
SHANGHAI NEW WORLD CO., LTD Stock Shanghai New World Co., Ltd
-13.98% 538M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.83% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+26.96% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.76% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+3.00% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.91% 231B
NOVARTIS AG Stock Novartis AG
+5.01% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.41% 195B
AMGEN INC. Stock Amgen Inc.
-6.26% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 600628 Stock
  4. Financials Shanghai New World Co., Ltd